Search Results

You're Searching on: HEALTHCARE
TOP PROS' TOP PICKS
Top Picks 2018: Cardinal Health (CAH)

Cardinal Health (CAH) is one of the “big three” wholesale drug distributors in the United States along with AmerisourceBergen (ABC) and McKesson (MCK), notes Ben Reynolds, editor of Sure Dividend. 

TOP PROS' TOP PICKS
Top Picks 2018: Emergent BioSolutions (EBS)

As the world faces an increasing onslaught of new threats from biological and chemical weapons, viruses, and epidemics, one company is making products and treatments to assuage these risks, suggests Doug Gerlach, editor of SmallCap Informer.

TOP PROS' TOP PICKS
Top Picks 2018: Sangamo Therapeutics (SGMO)

Over the past year, we witnessed the incredible transformation of Sangamo Therapeutics (SGMO) from a Wall Street has-been to a widely respected powerhouse in both gene therapy and gene editing, notes John McCamant, editor The Medical Technology Stock Letter.

TRADING IDEAS OF THE DAY
Investing the "William Wallace Way" in a Market on Fire

Some of the leaders include UnitedHealth Group, Northrop Grumman Corp. and Avery Dennison Corp. They all recently earned “A+” (Buy) Ratings, and are up 40.9%, 32.6% and 66.6%, respectively, in the last year, writes Mike Larson, senior analyst at Weiss Ratings.

TOP PROS' TOP PICKS
Top Picks 2018: Ecolab Inc. (ECL)

Ecolab (ECL) provides water, hygiene, and energy technologies for customers in the chemical, mining, power generation and petroleum industries, and we believe is positioned well an infrastructure re-build, explains John Eade, analyst with Argus Research.

TOP PROS' TOP PICKS
Top Picks 2018: Rite Aid (RAD)

Rite Aid (RAD) is our “Stock of the Year” because they have excellent fundamentals, a huge influx of cash from the sale to Walgreens, and less stores which will make it much easier to restructure, notes Bill Mathews, editor of The Cheap Investor.

TRADING IDEAS OF THE DAY
Glaxo SmithKline, United Healthcare in the Stealth Bull Market

Investors may expect to see a continuation of money flowing into the large pharmaceuticals. GSK and other similar stocks may back and fill over the next few days and weeks, asserts Joe Duarte, MD. He’s traded, analyzed and written about the markets since 1990.

TOP PROS' TOP PICKS
Top Picks 2018: Luxoft Holdings (LXFT)

Luxoft Holdings Inc. (LXFT) is a top pick for 2018; there are very few small cap enterprise technology stocks in a transition mode that generate significant amounts of cash, notes Peter Mantas, a value-focused money manager and editor of Logos LP Blog.

TOP PROS' TOP PICKS
Top Picks 2018: MannKind (MNKD)

After receiving a very positive label change for its lead product, Afrezza (an inhalable form of insulin), late in the year, MannKind (MNKD) also raised a sizable chunk of cash, notes Nate Pile, editor of Nate's Notes.

TOP PROS' TOP PICKS
Top Picks 2018: Utah Medical Products (UTMD)

Utah Medical Products (UTMD) manufactures medical devices for women and babies that are predominantly proprietary, disposable and for hospital use, explains Jim Fink, editor of Velocity Trader.

TOP PROS' TOP PICKS
Top Picks 2018: Integra Life Sciences Holdings (IART)

Integra Life Sciences Holdings Corp. (IART) is a leader in medical implants and instruments for neurosurgery, tissue regeneration and wound care, explains David Toung, analyst with Argus Research.

TOP PROS' TOP PICKS
Top Picks 2018: Omega Healthcare Industries (OHI)

Most dividend aristocrats gain their titles after a quarter-century – Omega Healthcare Industries (OHI) is making an accelerated case to be crowned in just six years’ time, explains Brett Owens, editor of Contrarian Outlook.

TOP PROS' TOP PICKS
Top Picks 2018: 22nd Century Group (XXII)

Whether for recreational or for medicinal purposes, marijuana is one of the hottest areas of biotechnology research. Pot is quickly losing its pariah status to become a huge, mainstream business, asserts growth stock expert John Persinos, editor of Breakthrough Tech Profits.

TOP PROS' TOP PICKS
Top Picks 2018: Glaxo Smithkline (GSK)

I’m not known for my patience when picking stocks. But once in a while a company comes along that begs for patience and even a momentum trader has to take notice, notes says Joe Duarte, editor of In the Money Options.

TOP PROS' TOP PICKS
Top Picks 2018: Nektar Therapeutics (NKTR)

Nektar Therapeutics (NKTR) had an incredible 2017 as their wholly-owned pipeline emerged on multiple fronts; the company is poised for a big 2018, asserts biotech expert John McCamant, editor The Medical Technology Stock Letter. 

TOP PROS' TOP PICKS
Top Picks 2018: General Electric (GE)

Our top conservative, income-oriented idea for for 2018 is General Electric (GE), asserts turnaround specialist George Putnam, editor of The Turnaround Letter.

TOP PROS' TOP PICKS
Clinical Research and Chemistry Boost PRA Health

PRA Health (PRAH) is a North Carolina-based clinical research organization (CRO) that provides outsourced services to biotech and pharmaceutical companies, ranging from basic chemistry to clinical development, trial enrollment and design, notes growth stock expert Mike Cintolo, editor of Cabot Top Ten Trader. 

TOP PROS' TOP PICKS
Emergent BioSolutions Targets Biological Threats

As the world faces an increasing onslaught of new threats from biological and chemical weapons, viruses, and epidemics, one company is making products and treatments to assuage these risks, suggests Doug Gerlach, editor of SmallCap Informer.